.

Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

McKesson
Johnson and Johnson
Julphar
Mallinckrodt
Farmers Insurance
Dow
QuintilesIMS
Chinese Patent Office
Teva
UBS

Generated: July 22, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 071322

« Back to Dashboard
NDA 071322 describes DIAZEPAM, which is a drug marketed by Martec Usa Llc, Upsher-smith Labs, Ferndale Labs, Actavis Elizabeth, Ivax Sub Teva Pharms, West-ward Pharms Int, Warner Chilcott, Watson Labs, Parenta Pharms, Us Army, Mylan, Dava Pharms Inc, Lannett Holdings Inc, Mayne Pharma, Vintage Pharms, Barr, Teva Pharms, Halsey, Roxane, Abraxis Pharm, Virtus Pharms, Watson Labs Inc, Marsam Pharms Llc, Pioneer Pharms, Hospira, and Duramed Pharms Barr, and is included in seventy-one NDAs. It is available from forty-five suppliers. Additional details are available on the DIAZEPAM profile page.

The generic ingredient in DIAZEPAM is diazepam. There are eight drug master file entries for this compound. Forty-nine suppliers are listed for this compound. Additional details are available on the diazepam profile page.

Summary for NDA: 071322

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Formulation / Manufacturing:see details

Pharmacology for NDA: 071322

Ingredient-typeBenzodiazepines

Suppliers and Packaging for NDA: 071322

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DIAZEPAM
diazepam
 TABLET;ORAL 071322 ANDA Teva Pharmaceuticals USA, Inc. 0172-3927 0172-3927-60 100 TABLET in 1 BOTTLE (0172-3927-60)
DIAZEPAM
diazepam
 TABLET;ORAL 071322 ANDA Teva Pharmaceuticals USA, Inc. 0172-3927 0172-3927-70 500 TABLET in 1 BOTTLE (0172-3927-70)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength10MG
Approval Date:Dec 10, 1986TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cipla
McKinsey
Queensland Health
Novartis
QuintilesIMS
Julphar
AstraZeneca
Cerilliant
Daiichi Sankyo
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Related Products from thinkBiotech
Links

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot